Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs – An Ab Initio Fragment Molecular Orbital Study
Sundaram Arulmozhiraja, Naoya Matsuo, Erika Ishitsubo, et al.
PLoS ONE (2016) Vol. 11, Iss. 11, pp. e0166275-e0166275
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Collagen derived Gly-Pro-type DPP-IV inhibitory peptides: Structure-activity relationship, inhibition kinetics and inhibition mechanism
Qiongyao Xu, Lin Zheng, Mingtao Huang, et al.
Food Chemistry (2024) Vol. 441, pp. 138370-138370
Closed Access | Times Cited: 16
In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes
Jirawat Riyaphan, Dinh‐Chuong Pham, Max K. Leong, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1877-1877
Open Access | Times Cited: 85
Role of hydrophobicity in food peptide functionality and bioactivity
Caleb Acquah, Elisa Di Stefano, Chibuike C. Udenigwe
Journal of Food Bioactives (2018), pp. 88-98
Open Access | Times Cited: 84
Bioactive Peptides as Potential Nutraceuticals for Diabetes Therapy: A Comprehensive Review
Priya Antony, Ranjit Vijayan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9059-9059
Open Access | Times Cited: 82
Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents
Vishal Mathur, Ozair Alam, Nadeem Siddiqui, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5860-5860
Open Access | Times Cited: 30
Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges
Kanghong Hu, Huizhong Huang, Hanluo Li, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1096-1096
Open Access | Times Cited: 26
Antidiabetic Potential of Senna siamea: α‐Glucosidase Inhibition, Postprandial Blood Glucose Reduction, Toxicity Evaluation, and Molecular Docking
Suthinee Sangkanu, Armad Heemman, Sathianpong Phoopha, et al.
Scientifica (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 1
Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl‐Chain Length and Hepatic Insulin Sensitivity in Mice
Takashi Matsuzaka, Motoko Kuba, Saori Koyasu, et al.
Hepatology (2019) Vol. 71, Iss. 5, pp. 1609-1625
Open Access | Times Cited: 57
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation
Inés Valencia, Susana Vallejo, Pilar Dongil, et al.
Hypertension (2022) Vol. 79, Iss. 7, pp. 1361-1373
Open Access | Times Cited: 31
Natural products from plants targeting key enzymes for the future development of antidiabetic agents
Rachel Mata, Laura Flores‐Bocanegra, Berenice Ovalle‐Magallanes, et al.
Natural Product Reports (2023) Vol. 40, Iss. 7, pp. 1198-1249
Closed Access | Times Cited: 20
Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer’s disease: a narrative review
Xin Jiang, Ji Li, Xiaohui Yao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
Giuseppe Coppolino, Christian Leporini, Laura Rivoli, et al.
Pharmacological Research (2017) Vol. 129, pp. 274-294
Open Access | Times Cited: 54
Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
Roger Yazbeck, Simone Jaenisch, Catherine A. Abbott
Biochemical Pharmacology (2021) Vol. 188, pp. 114517-114517
Open Access | Times Cited: 36
A review upon medicinal perspective and designing rationale of DPP-4 inhibitors
Shubham Kumar, Anu Mittal, Amit Mittal
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116354-116354
Closed Access | Times Cited: 34
In Silico Screening and Identification of Antidiabetic Inhibitors Sourced from Phytochemicals of Philippine Plants against Four Protein Targets of Diabetes (PTP1B, DPP-4, SGLT-2, and FBPase)
Mark Andrian B. Macalalad, Arthur A. Gonzales
Molecules (2023) Vol. 28, Iss. 14, pp. 5301-5301
Open Access | Times Cited: 16
Computational Modeling of the Interactions between DPP IV and Hemorphins
Priya Antony, Bincy Baby, Amie Jobe, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3059-3059
Open Access | Times Cited: 5
Activity and selectivity cliffs for DPP‐IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening
María José Ojeda, Aleix Gimeno, Sarah Tomas‐Hernández, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 6, pp. 1874-1915
Closed Access | Times Cited: 41
Dual-function peptides derived from egg white ovalbumin: Bioinformatics identification with validation using in vitro assay
Mohd Adam Salim Mohd Salim, Chee‐Yuen Gan
Journal of Functional Foods (2019) Vol. 64, pp. 103618-103618
Open Access | Times Cited: 39
DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
Alicja Krejner‐Bienias, Katarzyna Grzela, Tomasz Grzela
Archivum Immunologiae et Therapiae Experimentalis (2021) Vol. 69, Iss. 1
Open Access | Times Cited: 32
Harnessing cell-surface CD26 proteolysis-targeting chimeras for molecular targeted therapy against non-small cell lung cancer
Qiuyu Gong, Guangjian Zhang, Bohao Liu, et al.
Research Square (Research Square) (2025)
Closed Access
Identifying peptides from oat protein with potential hypocholesterolemic and satiety effects
Lijin Litson, Weixi Cai, Jingqi Yang, et al.
Journal of Functional Foods (2025) Vol. 128, pp. 106793-106793
Closed Access
Goat milk peptides—a potential nutraceutic to address type 2 diabetes mellitus
Anu Rahal, Amit Kumar, Ashok Kumar
(2025) Vol. 2, Iss. 2
Closed Access
Click Reaction Inspired Enzyme Inhibitors in Diabetes Care: An Update in the Field of Chronic Metabolic Disorder
Deeksha Mudgal, Nisha Yadav, Gaurav Kumar Srivastava, et al.
Current Pharmaceutical Design (2024) Vol. 31, Iss. 4, pp. 261-291
Closed Access | Times Cited: 3
Catechins anti-diabetic actions are mediated via multiple receptors, a mechanism deduced via molecular docking and dynamic simulations
Mohammad Salih, Mosab Yahya Al-Nour, Touqeer Ahmed, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access
Simultaneous Natural Deep Eutectic Solvent-Based Ultrasonic-Assisted Extraction of Bioactive Compounds of Cinnamon Bark and Sappan Wood as a Dipeptidyl Peptidase IV Inhibitor
Islamudin Ahmad, Ayun Erwina Arifianti, Aditya Sindu Sakti, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 3832-3832
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top